Inovio Pharmaceuticals
INO
#8986
Rank
โ‚ฌ0.10 B
Marketcap
1,50ย โ‚ฌ
Share price
3.57%
Change (1 day)
-16.52%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -2,53ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -2,48ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,40ย โ‚ฌ an increase over its 2023 EPS that were of -5,25ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,53ย โ‚ฌ-25.67%
2024-3,40ย โ‚ฌ-35.14%
2023-5,25ย โ‚ฌ-56.62%
2022-12,10ย โ‚ฌ-19.54%
2021-15,03ย โ‚ฌ35.9%
2020-11,06ย โ‚ฌ-11.57%
2019-12,51ย โ‚ฌ15.24%
2018-10,85ย โ‚ฌ-2.78%
2017-11,16ย โ‚ฌ6.93%
2016-10,44ย โ‚ฌ134.88%
2015-4,45ย โ‚ฌ-29.51%
2014-6,31ย โ‚ฌ-57.34%
2013-14,78ย โ‚ฌ146.55%
2012-6,00ย โ‚ฌ20.83%
2011-4,96ย โ‚ฌ-29.41%
2010-7,03ย โ‚ฌ-48.48%
2009-13,65ย โ‚ฌ10%
2008-12,41ย โ‚ฌ11.11%
2007-11,16ย โ‚ฌ-41.3%
2006-19,02ย โ‚ฌ-66.91%
2005-57,48ย โ‚ฌ110.61%
2004-27,29ย โ‚ฌ-61.63%
2003-71,12ย โ‚ฌ186.67%
2002-24,81ย โ‚ฌ
2001N/A-100%
2000-19,85ย โ‚ฌ-62.83%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,59ย โ‚ฌ-486.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,34ย โ‚ฌ-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,17ย โ‚ฌ-147.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
5,62ย โ‚ฌ-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,29ย โ‚ฌ-353.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,25ย โ‚ฌ-230.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-1,08ย โ‚ฌ-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA